ACRV

Insiders Updates

Understanding the Risks of Investing in Acrivon Therapeutics Inc (ACRV)

Daniel Torres

Acrivon Therapeutics Inc’s recent filing unveils that its President and CEO Blume-Jensen Peter acquired Company’s shares for reported $82124.0 on ...

Stock Earnings

Chief Operating Officer Devroe Eric acquire 10,000 shares of Acrivon Therapeutics Inc [ACRV]

Daniel Torres

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or ...

Knox Daily
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.